AAPL   382.05 (-0.18%)
MSFT   213.40 (-0.43%)
AMZN   3,189.38 (+0.21%)
NVDA   417.86 (-0.59%)
CGC   16.92 (+5.62%)
BABA   259.82 (-0.67%)
MU   50.08 (+0.20%)
GE   6.67 (+1.37%)
TSLA   1,492.12 (+7.02%)
T   30.18 (+2.17%)
ACB   11.87 (+0.85%)
F   6.05 (+3.42%)
GILD   76.39 (+2.25%)
DIS   118.95 (+1.82%)
BAC   23.92 (+5.01%)
NFLX   545.47 (+7.43%)
BA   178.43 (+2.97%)
AAPL   382.05 (-0.18%)
MSFT   213.40 (-0.43%)
AMZN   3,189.38 (+0.21%)
NVDA   417.86 (-0.59%)
CGC   16.92 (+5.62%)
BABA   259.82 (-0.67%)
MU   50.08 (+0.20%)
GE   6.67 (+1.37%)
TSLA   1,492.12 (+7.02%)
T   30.18 (+2.17%)
ACB   11.87 (+0.85%)
F   6.05 (+3.42%)
GILD   76.39 (+2.25%)
DIS   118.95 (+1.82%)
BAC   23.92 (+5.01%)
NFLX   545.47 (+7.43%)
BA   178.43 (+2.97%)
AAPL   382.05 (-0.18%)
MSFT   213.40 (-0.43%)
AMZN   3,189.38 (+0.21%)
NVDA   417.86 (-0.59%)
CGC   16.92 (+5.62%)
BABA   259.82 (-0.67%)
MU   50.08 (+0.20%)
GE   6.67 (+1.37%)
TSLA   1,492.12 (+7.02%)
T   30.18 (+2.17%)
ACB   11.87 (+0.85%)
F   6.05 (+3.42%)
GILD   76.39 (+2.25%)
DIS   118.95 (+1.82%)
BAC   23.92 (+5.01%)
NFLX   545.47 (+7.43%)
BA   178.43 (+2.97%)
AAPL   382.05 (-0.18%)
MSFT   213.40 (-0.43%)
AMZN   3,189.38 (+0.21%)
NVDA   417.86 (-0.59%)
CGC   16.92 (+5.62%)
BABA   259.82 (-0.67%)
MU   50.08 (+0.20%)
GE   6.67 (+1.37%)
TSLA   1,492.12 (+7.02%)
T   30.18 (+2.17%)
ACB   11.87 (+0.85%)
F   6.05 (+3.42%)
GILD   76.39 (+2.25%)
DIS   118.95 (+1.82%)
BAC   23.92 (+5.01%)
NFLX   545.47 (+7.43%)
BA   178.43 (+2.97%)
Log in

NASDAQ:XAIRBeyondAirInc . Stock Price, Forecast & News

$6.69
-0.23 (-3.32 %)
(As of 07/10/2020 02:51 PM ET)
Add
Compare
Today's Range
$6.69
Now: $6.69
$7.00
50-Day Range
$6.44
MA: $7.21
$8.42
52-Week Range
$3.45
Now: $6.69
$12.50
Volume4,045 shs
Average Volume368,175 shs
Market Capitalization$112.66 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.6
Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) delivery systems to treat respiratory tract infections and other diseases. Its NO delivery systems are used for the treatment of pulmonary hypertension of the newborn, bronchiolitis, and nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. The company is based in Garden City, New York.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.99 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:XAIR
CUSIPN/A
CIKN/A
Phone516-665-8200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.39 million
Book Value$1.24 per share

Profitability

Net Income$-19,940,000.00
Net Margins-203.22%

Miscellaneous

Employees18
Market Cap$112.66 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable

Receive XAIR News and Ratings via Email

Sign-up to receive the latest news and ratings for XAIR and its competitors with MarketBeat's FREE daily newsletter.

BeyondAirInc . (NASDAQ:XAIR) Frequently Asked Questions

How has BeyondAirInc .'s stock been impacted by COVID-19 (Coronavirus)?

BeyondAirInc .'s stock was trading at $5.32 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, XAIR shares have increased by 25.9% and is now trading at $6.70. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of BeyondAirInc .?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BeyondAirInc . in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for BeyondAirInc ..

When is BeyondAirInc .'s next earnings date?

BeyondAirInc . is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for BeyondAirInc ..

How were BeyondAirInc .'s earnings last quarter?

BeyondAirInc . (NASDAQ:XAIR) issued its quarterly earnings data on Monday, June, 22nd. The company reported ($0.36) earnings per share for the quarter, missing analysts' consensus estimates of ($0.35) by $0.01. The business earned ($0.20) million during the quarter, compared to analysts' expectations of $0.45 million. BeyondAirInc . had a negative return on equity of 162.21% and a negative net margin of 203.22%. View BeyondAirInc .'s earnings history.

What price target have analysts set for XAIR?

1 brokerages have issued 1-year price targets for BeyondAirInc .'s shares. Their forecasts range from $9.00 to $9.00. On average, they anticipate BeyondAirInc .'s stock price to reach $9.00 in the next year. This suggests a possible upside of 34.3% from the stock's current price. View analysts' price targets for BeyondAirInc ..

Has BeyondAirInc . been receiving favorable news coverage?

News articles about XAIR stock have been trending somewhat positive on Friday, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. BeyondAirInc . earned a news impact score of 1.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about BeyondAirInc ..

Who are some of BeyondAirInc .'s key competitors?

What other stocks do shareholders of BeyondAirInc . own?

Who are BeyondAirInc .'s key executives?

BeyondAirInc .'s management team includes the following people:
  • Mr. Steven Adam Lisi, CEO & Chairman (Age 48)
  • Mr. Amir Avniel, Co-Founder, Pres, COO & Director (Age 45)
  • Mr. Douglas J. Beck CPA, Chief Financial Officer (Age 58)
  • Mr. Adam Newman, Chief Legal Officer & Gen. Counsel
  • Mr. Duncan Fatkin, Chief Commercial Officer

What is BeyondAirInc .'s stock symbol?

BeyondAirInc . trades on the NASDAQ under the ticker symbol "XAIR."

How do I buy shares of BeyondAirInc .?

Shares of XAIR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is BeyondAirInc .'s stock price today?

One share of XAIR stock can currently be purchased for approximately $6.70.

How big of a company is BeyondAirInc .?

BeyondAirInc . has a market capitalization of $112.83 million and generates $1.39 million in revenue each year. The company earns $-19,940,000.00 in net income (profit) each year or ($1.53) on an earnings per share basis. BeyondAirInc . employs 18 workers across the globe.

What is BeyondAirInc .'s official website?

The official website for BeyondAirInc . is www.ait-pharm.com.

How can I contact BeyondAirInc .?

BeyondAirInc .'s mailing address is 825 EAST GATE BOULEVARD SUITE 320, GARDEN CITY NY, 11530. The company can be reached via phone at 516-665-8200.

This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.